Accessibility Menu
Surgical Science Sweden Ab (publ) logo

Surgical Science Sweden Ab (publ)

(OTC) SUSRF

Current Price$4.00
Market Cap$204.10M
Since IPO (2021)-71%
5 Year-71%
1 Year-74%
1 Month+41%

Surgical Science Sweden Ab (publ) Financials at a Glance

Market Cap

$204.10M

Revenue (TTM)

SEK 976.46M

Net Income (TTM)

SEK 52.12M

EPS (TTM)

$0.11

P/E Ratio

36.20

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$4.00

Volume

200

Open

$4.00

Previous Close

$4.00

Daily Range

$4.00 - $4.00

52-Week Range

$2.84 - $16.33

SUSRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Science Sweden Ab (publ)

Industry

Healthcare Equipment and Supplies

Employees

317

CEO

Tom Englund

Headquarters

Gothenburg, 412 50, SE

SUSRF Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

8%

Net Income Margin

5%

Return on Equity

1%

Return on Capital

2%

Return on Assets

1%

Earnings Yield

2.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$204.10M

Shares Outstanding

51.03M

Volume

200

Avg. Volume

7

Financials (TTM)

Gross Profit

SEK 575.46M

Operating Income

SEK 108.70M

EBITDA

SEK 191.86M

Operating Cash Flow

SEK 79.59M

Capital Expenditure

-SEK 11.65M

Free Cash Flow

SEK 67.95M

Cash & ST Invst.

SEK 614.88M

Total Debt

SEK 1.62M

Surgical Science Sweden Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 235.48M

-6.1%

Gross Profit

SEK 154.97M

-10.2%

Gross Margin

65.81%

N/A

Market Cap

$204.10M

N/A

Market Cap/Employee

$744.91K

N/A

Employees

274

N/A

Net Income

SEK 18.63M

-44.0%

EBITDA

SEK 22.87M

-4.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

SEK 665.58M

+8.9%

Accounts Receivable

SEK 311.36M

+0.9%

Inventory

SEK 207.50M

+10.4%

Long Term Debt

SEK 0.00

N/A

Short Term Debt

SEK 2.15M

+30.5%

Return on Assets

1.09%

N/A

Return on Invested Capital

1.65%

N/A

Free Cash Flow

SEK 47.35M

+402.5%

Operating Cash Flow

SEK 65.31M

+1417.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOVNFBioInvent International AB (publ)
$3.29+0.00%
COGZFCogstate Limited
$1.82-2.15%
VHIBFVitalhub Corp.
$5.30-0.38%
KSIOFKneat.com, Inc.
$3.84-0.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
IUSBiShares Trust - iShares Core Universal Usd Bond ETF
$46.15+0.00%
CZRCaesars Entertainment
$29.07+0.01%
RCATRed Cat
$14.15+0.33%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.48-0.02%

Questions About SUSRF

What is the current price of Surgical Science Sweden Ab (publ)?

Surgical Science Sweden Ab (publ) is trading at $4.00 per share.

What is the 52-week range for Surgical Science Sweden Ab (publ)?

Over the past 52 weeks, Surgical Science Sweden Ab (publ) has traded between $2.84 and $16.33.

How much debt does Surgical Science Sweden Ab (publ) have?

As of the most recent reporting period, Surgical Science Sweden Ab (publ) reported total debt of SEK 225.27K.

How much cash does Surgical Science Sweden Ab (publ) have on hand?

Surgical Science Sweden Ab (publ) reported SEK 70.09M in cash and cash equivalents in its most recent financial results.

What is Surgical Science Sweden Ab (publ)’s dividend yield?

Surgical Science Sweden Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.